Company: PHAT
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034183
Chunk: 125

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 16
Chunk 125
---
10-Q
      
    8-8-2024
     
    10.1

147

    10.8#
     
    Amended and Restated Employment Letter Agreement, dated September 25, 2019, by and between Azmi Nabulsi, M.D., M.P.H. and the Registrant 
     
    S-1
     
    9-30-2019
     
    10.9

    10.9#
     
    Form of Indemnification Agreement for Directors and Officers 
     
    S-1
     
    9-30-2019
     
    10.11

    10.10†
     
    License Agreement, dated May 7, 2019, by and between Takeda Pharmaceuticals Company Limited and the Registrant
     
    S-1
     
    9-30-2019
     
    10.12

    10.11#
     
    Employment Letter Agreement, dated August 29, 2019, by and between Terrie Curran and the Registrant
     
    S-1
     
    9-30-2019
     
    10.14

    10.12†
     
    Amendment No. 1 to Takeda License Agreement, dated September 21, 2020
     
    10-K
     
    3-30-2021
     
    10.20

    10.13†
     
    Supply and Packaging Services Agreement, by and between Sandoz GmbH and the Registrant, dated December 30, 2020
     
    10-K
     
    3-30-2021
     
    10.21

    10.14†
     
    Commercial Supply Agreement with Catalent Pharma Solutions, LLC entered into on July 2, 2021
     
    10-Q
     
    8-10-2021
     
    10.4

    10.15
     
    Loan and Security Agreement, dated September 17, 2021, by and among Hercules Capital and the Registrant
     
    10-Q
     
    11-8-2021
     
    10.1

    10.16†
     
    First